Genomictree Inventory

Genomictree (228760.KQ) currently reports a inventory of $350M as of June 2026. That compares with $340M in the prior-year period — up 1.9% year over year. Use the charts on this page to explore Genomictree's inventory history and peer comparisons.

Genomictree's inventory increased from $340M to $350M — a 1.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genomictree reported $350M in inventory as of June 2026. That compares with $340M in the prior-year period — up 1.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $350M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genomictree, and consider following 228760.KQ for alerts when major investors trade the stock.

Genomictree is classified in the Healthcare sector. On inventory, it currently shows $350M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 228760.KQ with unrelated industries.